FINWIRES · TerminalLIVE
FINWIRES

Apeloa Pharmaceutical Gets China Nod for Cholesterol-Lowering Drug

-- China's drug regulator approved Apeloa Pharmaceutical's (SHE:000739) registration for its fluvastatin sodium extended-release tablets, according to a Thursday filing with the Shenzhen bourse.

Fluvastatin sodium is indicated for cholesterol lowering, the filing said.

相關文章